United States Pharmaceuticals

Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals experienced significant selling activity recently, with insiders offloading over 105 million dollars in shares. Following a strong earnings report, the stock price rose 12 percent over three months. Executives and directors accounted for the bulk of these transactions, reflecting a net negative sentiment despite positive market performance and high valuation levels.
Ticker: REGN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Regeneron Pharmaceuticals, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
Pitofsky Jason SVP Controller Officer
Transaction date
Sale
Price
221.92
Quantity 19,887 +36.7%
Value US$1,898,480
2.4
Pitofsky Jason SVP Controller Officer
Transaction date
Sale
Price
113.43
Quantity 83,427 -19.4%
Value US$45,582
2.4
Pitofsky Jason SVP Controller Officer
Transaction date
Sale
Price
449.16
Quantity 10,866 -43.1%
Value US$779,024
2.4
Pitofsky Jason SVP Controller Officer
Transaction date
Sale
Price
943.53
Quantity 1,000 -10.7%
Value US$100,000
2.4
Pitofsky Jason SVP Controller Officer
Transaction date
Sale
Price
942.31
Quantity 1,000 -19.7%
Value US$100,000
2.4
Pitofsky Jason SVP Controller Officer
Transaction date
Sale
Price
941.58
Quantity 1,000 -13.8%
Value US$100,000
2.4
Pitofsky Jason SVP Controller Officer
Transaction date
Sale
Price
940.46
Quantity 1,000 -7.5%
Value US$100,000
2.4
Pitofsky Jason SVP Controller Officer
Transaction date
Sale
Price
939.57
Quantity 1,000 -5.4%
Value US$100,000
2.4
Jason Pitofsky Officer Officer
Transaction date
Proposed sale
Price
973.36
Quantity 1,000
Value US$100,000
2.4
Jason Pitofsky Officer Officer
Transaction date
Proposed sale
Price
976.00
Quantity 1,000
Value US$100,000
0.9
Zoghbi Huda Y Non-Executive Director
Transaction date
Sale
Price
971.06
Quantity 1,000 -22.7%
Value US$100,000
0.9
Zoghbi Huda Y Non-Executive Director
Transaction date
Sale
Price
970.42
Quantity 1,000 -75.9%
Value US$100,000
0.9
Huda Zoghbi Director Non-Executive Director
Transaction date
Proposed sale
Price
970.46
Quantity 1,000
Value US$100,000
3.8
SING GEORGE L Non-Executive Director
Transaction date
Sale
Price
970.18
Quantity 1,000 -0.8%
Value US$100,000
3.8
SING GEORGE L Non-Executive Director
Transaction date
Sale
Price
967.07
Quantity 1,000 -3.9%
Value US$100,000
3.8
SING GEORGE L Non-Executive Director
Transaction date
Sale
Price
966.27
Quantity 1,000 -5.5%
Value US$100,000
3.8
SING GEORGE L Non-Executive Director
Transaction date
Sale
Price
965.38
Quantity 1,000 -20.2%
Value US$100,000
3.8
SING GEORGE L Non-Executive Director
Transaction date
Sale
Price
964.57
Quantity 1,000 -7.1%
Value US$100,000
3.8
SING GEORGE L Non-Executive Director
Transaction date
Sale
Price
963.47
Quantity 1,000 -10.3%
Value US$100,000
3.8
SING GEORGE L Non-Executive Director
Transaction date
Sale
Price
962.61
Quantity 1,000 -5.7%
Value US$100,000
3.8
SING GEORGE L Non-Executive Director
Transaction date
Sale
Price
961.85
Quantity 1,000 -1.2%
Value US$100,000
3.8
SING GEORGE L Non-Executive Director
Transaction date
Sale
Price
960.57
Quantity 1,000 -2.6%
Value US$100,000
3.4
POON CHRISTINE A Non-Executive Director
Transaction date
Sale
Price
971.31
Quantity 1,000 -3.7%
Value US$100,000
3.4
POON CHRISTINE A Non-Executive Director
Transaction date
Sale
Price
970.51
Quantity 1,000 -14.7%
Value US$100,000
3.4
POON CHRISTINE A Non-Executive Director
Transaction date
Sale
Price
969.50
Quantity 1,000 -33.5%
Value US$100,000
3.4
POON CHRISTINE A Non-Executive Director
Transaction date
Sale
Price
968.58
Quantity 1,000 -20.7%
Value US$100,000
3.4
POON CHRISTINE A Non-Executive Director
Transaction date
Sale
Price
967.38
Quantity 1,000 -6.0%
Value US$100,000
3.4
POON CHRISTINE A Non-Executive Director
Transaction date
Sale
Price
966.74
Quantity 1,000 -1.7%
Value US$100,000
3.1
LAROSA JOSEPH J EVP General Counsel and Secret Officer
Transaction date
Sale
Price
966.11
Quantity 1,000 -1.3%
Value US$100,000
3.1
LAROSA JOSEPH J EVP General Counsel and Secret Officer
Transaction date
Sale
Price
965.41
Quantity 1,000 -9.1%
Value US$100,000
3.4
Christine Poon Director Non-Executive Director
Transaction date
Proposed sale
Price
961.26
Quantity 1,000
Value US$100,000
3.8
GEORGE L. SING Director Non-Executive Director
Transaction date
Proposed sale
Price
964.38
Quantity 1,000
Value US$100,000
3.1
Joseph LaRosa Officer Officer
Transaction date
Proposed sale
Price
965.49
Quantity 1,000
Value US$100,000
Guarini Kathryn Non-Executive Director
Transaction date
Planned sale
Price
900.00
Quantity 1,000 -39.9%
Value US$100,000
1.5
BROWN MICHAEL S Non-Executive Director
Transaction date
Planned sale
Price
875.00
Quantity 1,000 -58.3%
Value US$100,000
2.7
McCourt Marion EVP Commercial Officer
Transaction date
Planned sale
Price
869.43
Quantity 1,000 -9.4%
Value US$100,000
1.5
MICHAEL S BROWN Director Non-Executive Director
Transaction date
Proposed sale
Price
818.77
Quantity 1,000
Value US$100,000
Guarini Kathryn Director Non-Executive Director
Transaction date
Proposed sale
Price
900.00
Quantity 1,000
Value US$100,000
2.7
McCourt Marion Officer Officer
Transaction date
Proposed sale
Price
869.43
Quantity 1,000
Value US$100,000
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
781.47
Quantity 50 -0.1%
Value US$39,074
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
780.63
Quantity 463 -1.0%
Value US$361,432
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
779.59
Quantity 380 -0.8%
Value US$296,244
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
778.64
Quantity 454 -0.9%
Value US$353,503
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
777.76
Quantity 38 -0.1%
Value US$29,555
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
776.31
Quantity 66 -0.1%
Value US$51,236
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
775.46
Quantity 376 -0.8%
Value US$291,573
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
774.48
Quantity 121 -0.2%
Value US$93,712
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
773.40
Quantity 224 -0.4%
Value US$173,242
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
772.56
Quantity 211 -0.4%
Value US$163,010
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
771.56
Quantity 283 -0.6%
Value US$218,351
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
770.20
Quantity 12 -0.0%
Value US$9,242
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
769.30
Quantity 127 -0.3%
Value US$97,701
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
768.33
Quantity 105 -0.2%
Value US$80,675
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
767.39
Quantity 192 -0.4%
Value US$147,339
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
766.47
Quantity 279 -0.5%
Value US$213,845
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
765.39
Quantity 271 -0.5%
Value US$207,421
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
764.40
Quantity 219 -0.4%
Value US$167,404
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
763.76
Quantity 25 -0.0%
Value US$19,094
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
762.57
Quantity 55 -0.1%
Value US$41,941
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
761.36
Quantity 27 -0.1%
Value US$20,557
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
760.65
Quantity 74 -0.1%
Value US$56,288
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
759.96
Quantity 14 -0.0%
Value US$10,639
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
758.16
Quantity 24 -0.0%
Value US$18,196
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
757.68
Quantity 16 -0.0%
Value US$12,123
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
755.91
Quantity 35 -0.1%
Value US$26,457
MURPHY ANDREW J Co-Chief Scientific Officer Officer
Transaction date
Planned sale
Price
753.76
Quantity 6 -0.0%
Value US$4,523
MURPHY ANDREW J Officer Officer
Transaction date
Proposed sale
Price
772.70
Quantity 4,147
Value US$3,204,380
2.7
McCourt Marion EVP Commercial Officer
Transaction date
Planned sale
Price
857.39
Quantity 1,131 -8.6%
Value US$969,708
2.7
McCourt Marion Officer Officer
Transaction date
Proposed sale
Price
857.00
Quantity 1,131
Value US$969,267
2.7
McCourt Marion EVP Commercial Officer
Transaction date
Planned sale
Price
850.00
Quantity 1,215 -8.5%
Value US$1,032,750
Guarini Kathryn Non-Executive Director
Transaction date
Planned sale
Price
850.00
Quantity 400 -39.9%
Value US$340,000
2.7
McCourt Marion Officer Officer
Transaction date
Proposed sale
Price
850.00
Quantity 1,215
Value US$1,032,750
Guarini Kathryn Director Non-Executive Director
Transaction date
Proposed sale
Price
850.00
Quantity 400
Value US$340,000
Guarini Kathryn Non-Executive Director
Transaction date
Planned sale
Price
800.00
Quantity 400 -39.9%
Value US$320,000
0.9
Zoghbi Huda Y Non-Executive Director
Transaction date
Planned sale
Price
800.00
Quantity 800 -32.0%
Value US$640,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-06 2026-11-04 S Sale
2.4
Pitofsky Jason

SVP Controller

Officer
19,887 +36.7%
221.92
US$1,898,480 		19,887 +36.7% 221.92 US$1,898,480
2026-11-06 2026-11-04 S Sale
2.4
Pitofsky Jason

SVP Controller

Officer
83,427 -19.4%
113.43
US$45,582 		83,427 -19.4% 113.43 US$45,582
2026-11-06 2026-11-04 S Sale
2.4
Pitofsky Jason

SVP Controller

Officer
10,866 -43.1%
449.16
US$779,024 		10,866 -43.1% 449.16 US$779,024
2026-11-06 2026-11-04 S Sale
2.4
Pitofsky Jason

SVP Controller

Officer
1,000 -10.7%
943.53
US$100,000 		1,000 -10.7% 943.53 US$100,000
2026-11-06 2026-11-04 S Sale
2.4
Pitofsky Jason

SVP Controller

Officer
1,000 -19.7%
942.31
US$100,000 		1,000 -19.7% 942.31 US$100,000
2026-11-06 2026-11-04 S Sale
2.4
Pitofsky Jason

SVP Controller

Officer
1,000 -13.8%
941.58
US$100,000 		1,000 -13.8% 941.58 US$100,000
2026-11-06 2026-11-04 S Sale
2.4
Pitofsky Jason

SVP Controller

Officer
1,000 -7.5%
940.46
US$100,000 		1,000 -7.5% 940.46 US$100,000
2026-11-06 2026-11-04 S Sale
2.4
Pitofsky Jason

SVP Controller

Officer
1,000 -5.4%
939.57
US$100,000 		1,000 -5.4% 939.57 US$100,000
2026-11-04 2026-11-04 PrS Proposed sale
2.4
Jason Pitofsky

Officer

Officer
1,000
973.36
US$100,000 		1,000 973.36 US$100,000
2026-11-04 2026-11-04 PrS Proposed sale
2.4
Jason Pitofsky

Officer

Officer
1,000
976.00
US$100,000 		1,000 976.00 US$100,000
2026-11-05 2026-11-03 S Sale
0.9
Zoghbi Huda Y
Non-Executive Director
1,000 -22.7%
971.06
US$100,000 		1,000 -22.7% 971.06 US$100,000
2026-11-05 2026-11-03 S Sale
0.9
Zoghbi Huda Y
Non-Executive Director
1,000 -75.9%
970.42
US$100,000 		1,000 -75.9% 970.42 US$100,000
2026-11-03 2026-11-03 PrS Proposed sale
0.9
Huda Zoghbi

Director

Non-Executive Director
1,000
970.46
US$100,000 		1,000 970.46 US$100,000
2026-11-04 2026-11-02 S Sale
3.8
SING GEORGE L
Non-Executive Director
1,000 -0.8%
970.18
US$100,000 		1,000 -0.8% 970.18 US$100,000
2026-11-04 2026-11-02 S Sale
3.8
SING GEORGE L
Non-Executive Director
1,000 -3.9%
967.07
US$100,000 		1,000 -3.9% 967.07 US$100,000
2026-11-04 2026-11-02 S Sale
3.8
SING GEORGE L
Non-Executive Director
1,000 -5.5%
966.27
US$100,000 		1,000 -5.5% 966.27 US$100,000
2026-11-04 2026-11-02 S Sale
3.8
SING GEORGE L
Non-Executive Director
1,000 -20.2%
965.38
US$100,000 		1,000 -20.2% 965.38 US$100,000
2026-11-04 2026-11-02 S Sale
3.8
SING GEORGE L
Non-Executive Director
1,000 -7.1%
964.57
US$100,000 		1,000 -7.1% 964.57 US$100,000
2026-11-04 2026-11-02 S Sale
3.8
SING GEORGE L
Non-Executive Director
1,000 -10.3%
963.47
US$100,000 		1,000 -10.3% 963.47 US$100,000
2026-11-04 2026-11-02 S Sale
3.8
SING GEORGE L
Non-Executive Director
1,000 -5.7%
962.61
US$100,000 		1,000 -5.7% 962.61 US$100,000
2026-11-04 2026-11-02 S Sale
3.8
SING GEORGE L
Non-Executive Director
1,000 -1.2%
961.85
US$100,000 		1,000 -1.2% 961.85 US$100,000
2026-11-04 2026-11-02 S Sale
3.8
SING GEORGE L
Non-Executive Director
1,000 -2.6%
960.57
US$100,000 		1,000 -2.6% 960.57 US$100,000
2026-11-04 2026-11-02 S Sale
3.4
POON CHRISTINE A
Non-Executive Director
1,000 -3.7%
971.31
US$100,000 		1,000 -3.7% 971.31 US$100,000
2026-11-04 2026-11-02 S Sale
3.4
POON CHRISTINE A
Non-Executive Director
1,000 -14.7%
970.51
US$100,000 		1,000 -14.7% 970.51 US$100,000
2026-11-04 2026-11-02 S Sale
3.4
POON CHRISTINE A
Non-Executive Director
1,000 -33.5%
969.50
US$100,000 		1,000 -33.5% 969.50 US$100,000
2026-11-04 2026-11-02 S Sale
3.4
POON CHRISTINE A
Non-Executive Director
1,000 -20.7%
968.58
US$100,000 		1,000 -20.7% 968.58 US$100,000
2026-11-04 2026-11-02 S Sale
3.4
POON CHRISTINE A
Non-Executive Director
1,000 -6.0%
967.38
US$100,000 		1,000 -6.0% 967.38 US$100,000
2026-11-04 2026-11-02 S Sale
3.4
POON CHRISTINE A
Non-Executive Director
1,000 -1.7%
966.74
US$100,000 		1,000 -1.7% 966.74 US$100,000
2026-11-04 2026-11-02 S Sale
3.1
LAROSA JOSEPH J

EVP General Counsel and Secret

Officer
1,000 -1.3%
966.11
US$100,000 		1,000 -1.3% 966.11 US$100,000
2026-11-04 2026-11-02 S Sale
3.1
LAROSA JOSEPH J

EVP General Counsel and Secret

Officer
1,000 -9.1%
965.41
US$100,000 		1,000 -9.1% 965.41 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
3.4
Christine Poon

Director

Non-Executive Director
1,000
961.26
US$100,000 		1,000 961.26 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
3.8
GEORGE L. SING

Director

Non-Executive Director
1,000
964.38
US$100,000 		1,000 964.38 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
3.1
Joseph LaRosa

Officer

Officer
1,000
965.49
US$100,000 		1,000 965.49 US$100,000
2026-11-03 2026-10-30 PlS Planned sale
Guarini Kathryn
Non-Executive Director
1,000 -39.9%
900.00
US$100,000 		1,000 -39.9% 900.00 US$100,000
2026-11-03 2026-10-30 PlS Planned sale
1.5
BROWN MICHAEL S
Non-Executive Director
1,000 -58.3%
875.00
US$100,000 		1,000 -58.3% 875.00 US$100,000
2026-11-03 2026-10-30 PlS Planned sale
2.7
McCourt Marion

EVP Commercial

Officer
1,000 -9.4%
869.43
US$100,000 		1,000 -9.4% 869.43 US$100,000
2026-10-30 2026-10-30 PrS Proposed sale
1.5
MICHAEL S BROWN

Director

Non-Executive Director
1,000
818.77
US$100,000 		1,000 818.77 US$100,000
2026-10-30 2026-10-30 PrS Proposed sale
Guarini Kathryn

Director

Non-Executive Director
1,000
900.00
US$100,000 		1,000 900.00 US$100,000
2026-10-30 2026-10-30 PrS Proposed sale
2.7
McCourt Marion

Officer

Officer
1,000
869.43
US$100,000 		1,000 869.43 US$100,000
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
50 -0.1%
781.47
US$39,074 		50 -0.1% 781.47 US$39,074
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
463 -1.0%
780.63
US$361,432 		463 -1.0% 780.63 US$361,432
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
380 -0.8%
779.59
US$296,244 		380 -0.8% 779.59 US$296,244
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
454 -0.9%
778.64
US$353,503 		454 -0.9% 778.64 US$353,503
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
38 -0.1%
777.76
US$29,555 		38 -0.1% 777.76 US$29,555
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
66 -0.1%
776.31
US$51,236 		66 -0.1% 776.31 US$51,236
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
376 -0.8%
775.46
US$291,573 		376 -0.8% 775.46 US$291,573
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
121 -0.2%
774.48
US$93,712 		121 -0.2% 774.48 US$93,712
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
224 -0.4%
773.40
US$173,242 		224 -0.4% 773.40 US$173,242
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
211 -0.4%
772.56
US$163,010 		211 -0.4% 772.56 US$163,010
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
283 -0.6%
771.56
US$218,351 		283 -0.6% 771.56 US$218,351
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
12 -0.0%
770.20
US$9,242 		12 -0.0% 770.20 US$9,242
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
127 -0.3%
769.30
US$97,701 		127 -0.3% 769.30 US$97,701
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
105 -0.2%
768.33
US$80,675 		105 -0.2% 768.33 US$80,675
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
192 -0.4%
767.39
US$147,339 		192 -0.4% 767.39 US$147,339
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
279 -0.5%
766.47
US$213,845 		279 -0.5% 766.47 US$213,845
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
271 -0.5%
765.39
US$207,421 		271 -0.5% 765.39 US$207,421
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
219 -0.4%
764.40
US$167,404 		219 -0.4% 764.40 US$167,404
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
25 -0.0%
763.76
US$19,094 		25 -0.0% 763.76 US$19,094
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
55 -0.1%
762.57
US$41,941 		55 -0.1% 762.57 US$41,941
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
27 -0.1%
761.36
US$20,557 		27 -0.1% 761.36 US$20,557
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
74 -0.1%
760.65
US$56,288 		74 -0.1% 760.65 US$56,288
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
14 -0.0%
759.96
US$10,639 		14 -0.0% 759.96 US$10,639
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
24 -0.0%
758.16
US$18,196 		24 -0.0% 758.16 US$18,196
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
16 -0.0%
757.68
US$12,123 		16 -0.0% 757.68 US$12,123
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
35 -0.1%
755.91
US$26,457 		35 -0.1% 755.91 US$26,457
2026-10-15 2026-10-14 PlS Planned sale
MURPHY ANDREW J

Co-Chief Scientific Officer

Officer
6 -0.0%
753.76
US$4,523 		6 -0.0% 753.76 US$4,523
2026-10-14 2026-10-14 PrS Proposed sale
MURPHY ANDREW J

Officer

Officer
4,147
772.70
US$3,204,380 		4,147 772.70 US$3,204,380
2026-09-03 2026-09-03 PlS Planned sale
2.7
McCourt Marion

EVP Commercial

Officer
1,131 -8.6%
857.39
US$969,708 		1,131 -8.6% 857.39 US$969,708
2026-09-03 2026-09-03 PrS Proposed sale
2.7
McCourt Marion

Officer

Officer
1,131
857.00
US$969,267 		1,131 857.00 US$969,267
2026-09-03 2026-09-02 PlS Planned sale
2.7
McCourt Marion

EVP Commercial

Officer
1,215 -8.5%
850.00
US$1,032,750 		1,215 -8.5% 850.00 US$1,032,750
2026-09-03 2026-09-02 PlS Planned sale
Guarini Kathryn
Non-Executive Director
400 -39.9%
850.00
US$340,000 		400 -39.9% 850.00 US$340,000
2026-09-02 2026-09-02 PrS Proposed sale
2.7
McCourt Marion

Officer

Officer
1,215
850.00
US$1,032,750 		1,215 850.00 US$1,032,750
2026-09-02 2026-09-02 PrS Proposed sale
Guarini Kathryn

Director

Non-Executive Director
400
850.00
US$340,000 		400 850.00 US$340,000
2026-08-12 2026-08-10 PlS Planned sale
Guarini Kathryn
Non-Executive Director
400 -39.9%
800.00
US$320,000 		400 -39.9% 800.00 US$320,000
2026-08-12 2026-08-10 PlS Planned sale
0.9
Zoghbi Huda Y
Non-Executive Director
800 -32.0%
800.00
US$640,000 		800 -32.0% 800.00 US$640,000

See older Regeneron Pharmaceuticals, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Regeneron Pharmaceuticals, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Regeneron Pharmaceuticals, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America
Insider trades in S&P 500